BSE filing, NSE: ORCHPHARMA. Summary written from the filing by ALFA Finder's alert engine.
Orchid Pharma Ltd: key numbers
- Share price
- ₹891.00
- Market cap
- ₹5,336 Cr
- Revenue (annual)
- ₹811.3 Cr
- Net profit (annual)
- ₹20.55 Cr
- P/E (TTM)
- 615.6×Sector 46.1×
- Promoter holding
- 74.45%+4.61% QoQ
- FII holding
- 0.93%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Orchid Pharma Ltd
All →Orchid Pharma Partnership
Orchid Pharma entered a licensing and supply agreement with Laboratorio Libra for Exblifep across nine Latin American markets. The partnership is expected to represent a potential opportunity of about USD 80 million over 10 years.
Orchid Pharma Fund Raise of ₹600 Cr
Orchid Pharma's board approved an enabling resolution to raise funds of up to ₹600 Crore through equity or debt securities via various permissible modes.
- Value
- ₹600.0 Cr
Orchid Pharma Other Announcement
The company submitted its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026.
Orchid Pharma Other Announcement
Orchid Pharma Ltd has filed its quarterly Shareholding Pattern, providing a routine update on promoter and public shareholding as mandated by SEBI regulations.
Orchid Pharma Annual General Meeting
Orchid Pharma held its 33rd Annual General Meeting on September 29, 2026, where shareholders considered and approved routine business resolutions and related party transactions.
Orchid Pharma Capital Structure Change
Orchid Pharma Limited received trading approval for 4,45,86,052 equity shares issued under its NCLT-sanctioned scheme of amalgamation, effective September 23, 2026.
Other board meeting date announcements
All →HMT Board Meeting Date
HMT Ltd will hold a board meeting on 6 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. The notice is advance intimation only.
Svarnim Trade Udyog Board Meeting Date
Svarnim Trade Udyog will hold a board meeting on 3 November 2026 to consider unaudited quarterly and half-year results. No amounts are stated.
Intrasoft Technologies Board Meeting Date
Intrasoft Technologies will hold a board meeting on 06-Nov-2026 to consider unaudited standalone and consolidated results for the quarter and half-year ended September 30, 2026. Trading window remains closed until 48 hours after the meeting.
Ruparel Food Products Board Meeting Date
Ruparel Food Products will hold a board meeting on 02-Nov-2026 to consider unaudited standalone and consolidated half-yearly financial results for September 2026. Trading window is closed from 01-Oct-2026.
Accedere Board Meeting Date
Accedere Limited intimated a board meeting on 4 November 2026 to consider its unaudited Q2 standalone and consolidated results. Trading window closure is also noted, so this is a future meeting notice.
Systematic Industries Board Meeting Date
Systematic Industries Limited intimates a board meeting on November 3, 2026, to consider unaudited standalone results for the half year ended September 30, 2026. The trading window is closed from October 1, 2026 until 48 hours after the results are declared.